treatment-naïve or relapsed/refractory chronic lymphocytic leukemia research hub

CLL-Frail - A prospective, multicenter phase II trial of acalabrutinib in very old (≥80y) or frail CLL-Patients

This study looks at a medicine called Calquence for older or weaker patients with a type of blood cancer called CLL. It's for people who haven't had treatment before or whose cancer has come back. We want to see how well the medicine works after about six months.